For healthcare professionals only

Where

Online

When

June 25, 2020

Time

1:00 pm
& 7:00 pm
Share on facebook
Share on twitter
Share on linkedin
Share on email

Getting the timing right: when to consider a GLP-1 receptor agonist in type 2 diabetes

Speaker: Speaker: John Doe, Professor in XXXXXX XXXXXXXXX, London

Join us at either 1pm or 7pm, for an hour, and ask your questions.

This webinar has been developed, organised and funded by Novo Nordisk Ltd. Novo Nordisk has reviewed the content prior to broadcast.

Agenda


  • lorem ipsum text for explanation of the presentation.

  • lorem ipsum text for explanation of the presentation.

  • lorem ipsum text for explanation of the presentation.

* Mandatory Field
Your data is being collected by OmniaMed Communications on behalf of Novo Nordisk solely for the purpose of processing your registration. Your details will not be shared with any parties other than OmniaMed Communications and Novo Nordisk.

We use cookies to ensure that we give you the best experience on our website. Some may have been set already. If you continue without changing your settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies. If you have any concerns about this, please click here to find out more.

This website is for healthcare professionals

This website is for UK and ROI healthcare professionals only. To continue, please confirm that you are a UK or ROI healthcare professional by clicking the ‘Confirm’ button below.